{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-082708","form_type":"8-K/A","ticker":"HCTI","cik":"0001839285","company_name":"Healthcare Triangle, Inc.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.279329+00:00","generated_at":"2026-05-17T08:57:14.632665+00:00","sec_items":["9.01","1.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"HCTI amends acquisition terms to give seller 1.388M shares after reverse split; discloses audited financials","bullets":["Amendment replaces stock consideration with 1,388,041 restricted shares, reflecting 1-for-249 reverse split, subject to shareholder approval.","Niyama audited FY2024: revenue $3K, net loss $37K; Ezovion: revenue $258K, net income $13K.","Pro forma combined FY2024 revenue $11.96M, net loss $5.99M; HCTI standalone had $1.1M AR and $2.65M short-term borrowing.","HCTI standalone total liabilities $9.78M vs total assets $7.66M; combined assets $8.24M.","Acquired entities contribute minimal revenue/assets relative to HCTI's existing losses; deal still requires shareholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-082708","json":"https://secwatch.observer/filing/0001213900-25-082708.json","markdown":"https://secwatch.observer/filing/0001213900-25-082708.md","text":"https://secwatch.observer/filing/0001213900-25-082708.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/0001213900-25-082708-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/ea0255323-8ka1_health.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:57:14.632665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}